| Assay ID | Title | Year | Journal | Article |
|---|
| AID1683486 | Inhibition of Tyrosinase (unknown origin) using tyrosine as substrate incubated for 20 mins followed by substrate addition and measured every 10 mins for 30 mins | 2021 | Bioorganic & medicinal chemistry, 01-01, Volume: 29 | Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity. |
| AID633113 | Antibacterial activity against Bacillus cereus ATCC 11778 | 2011 | Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
| The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity. |
| AID1683485 | Inhibition of Elastase (unknown origin) at 150 uM using N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide as substrate at 150 uM incubated for 20 mins followed by substrate addition and measured after 40 mins relative to control | 2021 | Bioorganic & medicinal chemistry, 01-01, Volume: 29 | Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity. |
| AID1357643 | Cytotoxicity against mouse 3T3L1 cells at 50 uM after 24 hrs by sulforhodamine B assay | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Lipid reducing activity and toxicity profiles of a library of polyphenol derivatives. |
| AID633114 | Antibacterial activity against Staphylococcus aureus ATCC 2587 | 2011 | Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
| The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity. |
| AID1357644 | Cytotoxicity against mouse 3T3L1 cells at 50 uM after 48 hrs by sulforhodamine B assay | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Lipid reducing activity and toxicity profiles of a library of polyphenol derivatives. |
| AID240726 | Concentration required to inhibit monoamine oxidase activity by 50% | 2004 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 14, Issue:22
| QSAR modeling of the MAO inhibitory activity of xanthones derivatives. |
| AID1683483 | Inhibition of Collagenase (unknown origin) using FALGPA as substrate at 150 uM incubated for 20 mins followed by substrate addition and measured after 60 mins relative to control | 2021 | Bioorganic & medicinal chemistry, 01-01, Volume: 29 | Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity. |
| AID633116 | Antibacterial activity against Moraxella catarrhalis ATCC 232446 | 2011 | Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
| The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity. |
| AID1683487 | Inhibition of Tyrosinase (unknown origin) at 150 uM using tyrosine as substrate incubated for 20 mins followed by substrate addition and measured every 10 mins for 30 mins relative to control | 2021 | Bioorganic & medicinal chemistry, 01-01, Volume: 29 | Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity. |
| AID633117 | Antifungal activity against Cryptococcus neoformans ATCC 90112 | 2011 | Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
| The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity. |
| AID1357647 | Lipid lowering activity in zebrafish embryos at 5 uM by Nile red fat metabolism assay | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Lipid reducing activity and toxicity profiles of a library of polyphenol derivatives. |
| AID1357641 | Toxicity in zebra fish larvae at 5 uM after 48 hrs | 2018 | European journal of medicinal chemistry, May-10, Volume: 151 | Lipid reducing activity and toxicity profiles of a library of polyphenol derivatives. |
| AID633118 | Antifungal activity against Candida albicans ATCC 10231 | 2011 | Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
| The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity. |
| AID1683488 | Inhibition of Hyaluronidase (unknown origin) at 9.4 to 150 uM using hyaluronic acid as substrate incubated for 20 mins followed by substrate addition and measured after 40 mins | 2021 | Bioorganic & medicinal chemistry, 01-01, Volume: 29 | Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity. |
| AID633115 | Antibacterial activity against Escherichia coli ATCC 8739 | 2011 | Bioorganic & medicinal chemistry letters, Dec-01, Volume: 21, Issue:23
| The synthesis of xanthones, xanthenediones, and spirobenzofurans: their antibacterial and antifungal activity. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6
| A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | | | |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6
| A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |